Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Specific T Cell Activation in Malignant Brain Tumors
Malte Mohme, Marian C. Neidert
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion
Ester Gangoso, Benjamin Southgate, Leanne Bradley, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2454-2470.e26
Open Access | Times Cited: 270
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 60
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Brandon L. McClellan, Santiago Haase, Felipe J. Núñez, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 2
Open Access | Times Cited: 39
Current approaches in glioblastoma multiforme immunotherapy
Marjan Aghajani, Nazila Jalilzadeh, Ali Aghebati‐Maleki, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1584-1612
Closed Access | Times Cited: 13
Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 10
T lymphocytes as dynamic regulators of glioma pathobiology
Elizabeth Cordell, Mahmoud S. Alghamri, María G. Castro, et al.
Neuro-Oncology (2022) Vol. 24, Iss. 10, pp. 1647-1657
Open Access | Times Cited: 31
Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma
Yanhua Mou, Lu Zhang, Zhantao Liu, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
Samuel Rivero-Hinojosa, Melanie Grant, Aswini K. Panigrahi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Role of Serotonergic System in Regulating Brain Tumor-Associated Neuroinflammatory Responses
Surojit Karmakar, Girdhari Lal
Methods in molecular biology (2024), pp. 181-207
Closed Access | Times Cited: 4
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)
Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 17
Comprehensive causal analysis between autoimmune diseases and glioma: A Mendelian randomization study
Ni Deng, Rafeq Agila, Qiang He, et al.
Medicine (2025) Vol. 104, Iss. 10, pp. e41815-e41815
Open Access
Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance
Dana K. Mitchell, Jack Shireman, Elizabeth A. Sierra Potchanant, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 20
Immunotherapeutic Approaches for the Treatment of Glioblastoma Multiforme: Mechanism and Clinical Applications
Suprava Das, Banendu Sunder Dash, Thejas P. Premji, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10546-10546
Open Access | Times Cited: 7
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
Viktoria Melcher, Kornelius Kerl
Cancers (2021) Vol. 13, Iss. 22, pp. 5601-5601
Open Access | Times Cited: 15
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies
Kristin G. Anderson, David A. Braun, Aitziber Buqué, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006533-e006533
Open Access | Times Cited: 6
Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3655-3655
Open Access | Times Cited: 6
Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide
Gilbert Aaron Lee, Wanli Lin, Duen-Pang Kuo, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 5233-5246
Open Access | Times Cited: 13
Advanced Immunotherapy Approaches for Glioblastoma
Yifan Ma, Zhaogang Yang, Kristin Huntoon, et al.
Advanced Therapeutics (2021) Vol. 4, Iss. 8
Closed Access | Times Cited: 13
Virus-Based Immuno-Oncology Models
Juliana Sitta, Pier Paolo Claudio, Candace M. Howard
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1441-1441
Open Access | Times Cited: 10
Emerging Nano‐Immunotherapeutic Approaches to Glioma
Nan Jin, Wei Yang, Yujie Xie, et al.
Small Structures (2023) Vol. 4, Iss. 8
Open Access | Times Cited: 5
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Daniel Picard, Jörg Felsberg, Maike Langini, et al.
Acta Neuropathologica (2023) Vol. 146, Iss. 4, pp. 551-564
Open Access | Times Cited: 5
Emerging Biomarkers for Immunotherapy in Glioblastoma
Nadia Mensali, Else Marit Inderberg
Cancers (2022) Vol. 14, Iss. 8, pp. 1940-1940
Open Access | Times Cited: 9
T‐cell activation is associated with high‐grade serous ovarian cancer survival
Lei Wang, Wenjie Sun, Guoan Zhang, et al.
Journal of Obstetrics and Gynaecology Research (2022) Vol. 48, Iss. 8, pp. 2189-2197
Closed Access | Times Cited: 8
Drug resistance in glioblastoma: from chemo- to immunotherapy
Sachin Sharma, Oksana Chepurna, Tao Sun
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 688-708
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top